Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gyre Therapeutics

10.19
-0.0900-0.88%
Volume:108.55K
Turnover:1.10M
Market Cap:879.73M
PE:203.80
High:10.58
Open:10.25
Low:9.80
Close:10.28
Loading ...

BRIEF-Gyre Therapeutics Entered Into Open Market Sale Agreement, May Offer & Sell Shares Of Common Stock Of Up To $50 Million From Time To Time

Reuters
·
28 Nov 2024

Gyre Therapeutics: Entered Into Open Market Sale Agreement, May Offer & Sell Shares of Common Stock of up to $50 Mln From Time to Time - SEC Filing

THOMSON REUTERS
·
28 Nov 2024

Gyre Therapeutics Third Quarter 2024 Earnings: EPS: US$0.013 (vs US$0.68 loss in 3Q 2023)

Simply Wall St.
·
15 Nov 2024

Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates

TIPRANKS
·
15 Nov 2024

Gyre Therapeutics Files $150 Million Mixed Securities Shelf

MT Newswires Live
·
15 Nov 2024

Gyre Therapeutics Inc Files for Mixed Shelf of up to $150 Mln – SEC Filing

THOMSON REUTERS
·
15 Nov 2024

BRIEF-Gyre Therapeutics Reports Third Quarter 2024 And Year-To-Date Financial Results And Provides Business Update

Reuters
·
13 Nov 2024

Gyre Therapeutics Q3 Earnings, Revenue Decline

MT Newswires Live
·
13 Nov 2024

Gyre Therapeutics Q3 2024 GAAP EPS Of $0.01 Vs. $0.05 YoY, With Adjusted Net Income Of $4.39M Vs. $11.19M YoY

Benzinga
·
13 Nov 2024

Gyre Therapeutics Inc: Qtrly EPS $0.01

THOMSON REUTERS
·
13 Nov 2024

Gyre Therapeutics Reports Third Quarter 2024 and Year-to-Date Financial Results and Provides Business Update

THOMSON REUTERS
·
13 Nov 2024

Gyre Therapeutics Q3 Net Income USD 2.9 Million

THOMSON REUTERS
·
13 Nov 2024

Corrected-Gyre Therapeutics Q3 Revenue USD 25.5 Million (Corrects Amount)

THOMSON REUTERS
·
13 Nov 2024

Gyre Therapeutics Q3 Revenue USD 25.3 Million

THOMSON REUTERS
·
13 Nov 2024

Press Release: Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Dow Jones
·
13 Nov 2024

BRIEF-Gyre Therapeutics announces last patient completed pivotal phase 3 trial evaluating F351 For CHB-associated liver fibrosis

Reuters
·
23 Oct 2024